Page last updated: 2024-08-25

palinavir and amprenavir

palinavir has been researched along with amprenavir in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Abbenante, G; Fairlie, DP; Leung, D	1
Anderson, PC; Beaulieu, PL; Cameron, DR; Croteau, G; Gorys, V; Grand-Maître, C; Lamarre, D; Liard, F; Paris, W; Pav, S; Plamondon, L; Soucy, F; Thibeault, D; Tong, L; Wernic, D; Yoakim, C	1

Reviews

1 review(s) available for palinavir and amprenavir

Article	Year
Protease inhibitors: current status and future prospects. Journal of medicinal chemistry, 2000, Feb-10, Volume: 43, Issue:3 Topics: Animals; Aspartic Acid Endopeptidases; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Humans; Metalloendopeptidases; Models, Molecular; Protease Inhibitors; Serine Endopeptidases; Serine Proteinase Inhibitors	2000

Other Studies

1 other study(ies) available for palinavir and amprenavir

Article	Year
2',6'-Dimethylphenoxyacetyl: a new achiral high affinity P(3)-P(2) ligand for peptidomimetic-based HIV protease inhibitors. Journal of medicinal chemistry, 2000, Mar-23, Volume: 43, Issue:6 Topics: Administration, Oral; Animals; Biological Availability; Cell Line; Crystallography, X-Ray; Drug Evaluation, Preclinical; HIV Protease Inhibitors; HIV-1; Ligands; Models, Molecular; Pyridines; Rats; Stereoisomerism; Structure-Activity Relationship; Virus Replication	2000

Article

Year

2',6'-Dimethylphenoxyacetyl: a new achiral high affinity P(3)-P(2) ligand for peptidomimetic-based HIV protease inhibitors.

Journal of medicinal chemistry, 2000, Mar-23, Volume: 43, Issue:6

Topics: Administration, Oral; Animals; Biological Availability; Cell Line; Crystallography, X-Ray; Drug Evaluation, Preclinical; HIV Protease Inhibitors; HIV-1; Ligands; Models, Molecular; Pyridines; Rats; Stereoisomerism; Structure-Activity Relationship; Virus Replication

2000